metoprolol has been researched along with Parkinson Disease, Secondary in 1 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case report is presented documenting definite beneficial effect of metoprolol, a beta-selective adrenoceptor antagonist, in alleviating neuroleptic-induced coarse tremors." | 7.67 | Metoprolol in the treatment of neuroleptic-induced tremor: case report. ( Chaturvedi, SK, 1987) |
| "A case report is presented documenting definite beneficial effect of metoprolol, a beta-selective adrenoceptor antagonist, in alleviating neuroleptic-induced coarse tremors." | 3.67 | Metoprolol in the treatment of neuroleptic-induced tremor: case report. ( Chaturvedi, SK, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaturvedi, SK | 1 |
1 other study available for metoprolol and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Metoprolol in the treatment of neuroleptic-induced tremor: case report.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Humans; Male; Metoprolol; Parkinson Disease, Seco | 1987 |